Approval · Notice of Compliance 4040 · 1997
ACCUPRO: Notice of Compliance 4040
Issued December 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4040
- Date
- December 15, 1997
- Company
- Parke-Davis Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCUPRO | 02236987 | — |
| ACCUPRO | 02236988 | — |
| ACCUPRO | 02236989 | — |
| ACCUPRO | 02236990 | — |
Medicinal ingredients
- QUINAPRIL HCL 5 MG per TAB
- QUINAPRIL HCL 10 MG per TAB
- QUINAPRIL HCL 20 MG per TAB
- QUINAPRIL HCL 40 MG per TAB